GSK, CureVac partnership eyes Covid-19 vaccine against multiple variants

GSK, CureVac partnership eyes Covid-19 vaccine against multiple variants GSK, which holds a stake in CureVac, will also support the production of up to 100 million doses of CureVac's first-generation Covid-19 vaccine candidate in 2021, they said. https://ift.tt/eA8V8J